公开(公告)号：US06425863B1

公开(公告)日：2002-07-30

申请号：US09646848

申请日：2001-02-28

申请人： Karl Werner ,  Peter Blasberg ,  Wilfried Muller

发明人： Karl Werner ,  Peter Blasberg ,  Wilfried Muller

IPC分类号： A61B500

CPC分类号： G06F19/3456 ,  A61B5/14532 ,  G06F19/00 ,  G06F19/324 ,  Y10S128/92 ,  Y10S128/921

摘要： Method for monitoring insulin medication in which blood sugar values are determined before and after a meal. The difference between these measured values is plotted against a quotient calculated from the bread units ingested during the meal and the insulin units used to compensate for these bread units. Displaying many such points on a graph provides criteria for improving the insulin medication.

摘要翻译： 用于监测膳食前后测定血糖值的胰岛素药物的方法。 将这些测量值之间的差值与从膳食期间摄入的面包单位和用于补偿这些面包单位的胰岛素单位计算的商相比。 在图上显示许多这样的点提供了改善胰岛素药物的标准。

公开(公告)号：US10430613B2

公开(公告)日：2019-10-01

申请号：US14016878

申请日：2013-09-03

申请人： Karl Werner ,  Ulrich Porsch ,  Stefan Riebel

发明人： Karl Werner ,  Ulrich Porsch ,  Stefan Riebel

IPC分类号： G01N33/48 ,  G06F21/64 ,  G06F19/00 ,  G06F21/51 ,  G16H40/63 ,  G16H10/40

摘要： A blood glucose measuring device and method for transmitting measured bG values to an external device such as a computer with improved data integrity for greater reliability is disclosed. The measuring device comprises a measuring means for determining measured blood glucose values, a measured value memory in which the measured blood glucose values are stored, a data interface that is configured for a data exchange with an external data reading apparatus, and a data file system which comprises a data reading application which can be accessed by the external data reading apparatus in order to read the stored measured blood glucose values, wherein the data system file further comprises a test application that is configured to execute an integrity test for the data reading application by forming a current digital signature for the data reading application and comparing this with a digital test signature provided in the data file system.

公开(公告)号：US09918635B2

公开(公告)日：2018-03-20

申请号：US12818310

申请日：2010-06-18

申请人： Steven Bousamra ,  Stefan Weinert ,  Juergen Rasch-Menges ,  P. Douglas Walling ,  John F. Price ,  Heino Eikmeier ,  Birgit Kraeling ,  Karl Werner ,  Ulrich Porsch

发明人： Steven Bousamra ,  Stefan Weinert ,  Juergen Rasch-Menges ,  P. Douglas Walling ,  John F. Price ,  Heino Eikmeier ,  Birgit Kraeling ,  Karl Werner ,  Ulrich Porsch

IPC分类号： A61B5/00 ,  A61B5/145 ,  G06F19/00 ,  A61M31/00 ,  A61B5/05 ,  C12Q1/00

CPC分类号： A61B5/0002 ,  A61B5/05 ,  A61B5/14532 ,  A61B5/14546 ,  A61M31/00 ,  A61M2230/201 ,  C12Q1/006 ,  G06F19/00 ,  G06F19/3418 ,  G06F19/3456 ,  G16H10/20 ,  G16H10/40 ,  G16H20/17 ,  G16H80/00

摘要： Embodiments of a testing method suitable for diabetic persons to optimize their administered insulin dosage comprise collecting one or more sampling sets of biomarker data, wherein each sampling set comprises a sufficient plurality of non-adverse sampling instances and wherein each sampling instance comprises an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and if the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized. The insulin dosage is optimized when one or more biomarker sampling parameters fall within a target biomarker range.

公开(公告)号：US07906479B2

公开(公告)日：2011-03-15

申请号：US12100674

申请日：2008-04-10

申请人： Matthias Rischer ,  Horst Mueller ,  Karl Werner ,  Juergen Engel

发明人： Matthias Rischer ,  Horst Mueller ,  Karl Werner ,  Juergen Engel

IPC分类号： A01N37/18 ,  A61K38/00

CPC分类号： A61K9/19 ,  A61K9/0019 ,  A61K9/10 ,  A61K31/19 ,  A61K38/09 ,  A61K47/26 ,  G06F19/00 ,  A61K2300/00

摘要： The invention provides sterile suspensions and sterile lyophilizates of slightly soluble basic peptide complexes, and pharmaceutical formulations comprising them. The provided sterile suspensions, sterile lyophilizates and pharmaceutical formulations comprising them are particularly suitable for use in a parenteral dosage form as medicaments for the treatment and prophylaxis of diseases and pathological states in mammals, especially in humans.

摘要翻译： 本发明提供无菌悬浮液和微溶性碱性肽复合物的无菌冻干物和包含它们的药物制剂。 提供的无菌悬浮液，无菌冻干物和包含它们的药物制剂特别适用于肠胃外剂型，作为用于治疗和预防哺乳动物，特别是人的疾病和病理状态的药物。

公开(公告)号：US20060161212A1

公开(公告)日：2006-07-20

申请号：US11276134

申请日：2006-02-15

申请人： Juergen Rasch-Menges ,  Karl Werner ,  Frederic Wehowski

发明人： Juergen Rasch-Menges ,  Karl Werner ,  Frederic Wehowski

IPC分类号： A61N1/378

CPC分类号： G01R31/382 ,  A61B5/14532 ,  A61B2560/0214 ,  G01R31/3646 ,  G01R31/392

摘要： The invention generally related to a method and device for displaying the remaining serviceable life of a battery-operated analytical device for analysis of a medically-relevant component of a body fluid, in particular of a blood glucose measuring device.

摘要翻译： 本发明一般涉及用于显示电池操作的分析装置的剩余使用寿命的方法和装置，用于分析体液的医疗相关部件，特别是血糖测量装置。